Jeffrey N. Wasserstein focuses on pharmaceutical and medical device promotion, as well as health care fraud and abuse. He also provides counsel on health privacy (HIPAA) and general food and drug law, specializing in the intersection of FDA and health care law. Mr. Wasserstein is a member of several promotional review committees of pharmaceutical and medical device companies. In these roles, he evaluates promotional materials and conducts internal audits of marketing and promotional practices, develops standard operating procedures and policies, and provides training to legal, regulatory, and marketing departments. Mr. Wasserstein also advises on the marketing and promotion of in vitro diagnostic devices.

Mr. Wasserstein is the co-founding blogger of the FDA Law Blog, the industry’s foremost resource for insight on food and drug regulation and enforcement actions. He is widely regarded as an industry thought leader in the use of social media to market regulated products that fall under the purview of FDA and the FTC: pharmaceuticals, biotech, medical devices, as well as foods and supplements. Mr. Wasserstein authored a chapter on social media, “Using Social Media in FDA-Regulated Industries: The Essential Guide,” FDLI, 2010. He also advises an online publisher on social media best practices with regard to regulated industries.